• Samsung Biologics Expands Vaccine Manufacturing Capabilities contractpharma
    June 02, 2021
    ​Samsung Biologics, a global CDMO providing end-to-end contract development and manufacturing services, unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within ...
  • MedPharm Opens New Manufacturing Facility contractpharma
    June 02, 2021
    State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.
  • Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services prnasia
    June 01, 2021
    Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier part of the year in 2022.
  • Trends to watch out for in the pharmaceutical robot market europeanpharmaceuticalreview
    April 26, 2021
    EPR’s Hannah Balfour summarises a market research report exploring trends in the pharmaceutical robot market between 2021 and 2028.
  • Catalent Biologics Completes Madison Expansion contractpharma
    April 14, 2021
    ​Catalent has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, WI, and began work on customer programs.
  • Sanofi Invests in Cutting Edge Vax Production Site in Singapore contractpharma
    April 13, 2021
    The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.
  • Steriline Delivers New Manufacturing Line to Bess Pro contractpharma
    April 01, 2021
    ​Steriline, a highly specialized manufacturer of complete lines for the aseptic processing of injectable drugs, has successfully delivered a new line to bess pro gmbh, a Berlin located company part of the bess group, manufacturing and distributing ...
  • Thermo Fisher Scientific Further Expands Global Footprint contractpharma
    December 11, 2020
    Thermo Fisher Scientific will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines.
  • Career prospects in pharma in the new normal expresspharma
    December 07, 2020
    The manpower needs in the pharma industry are foremost in manufacturing, quality assurance, quality control and sales, followed by other functions like HR, IT, and marketing. In this article, we’ll focus on career prospects in the top key domains of ...
  • Lonza Expands HPAPI Capabilities contractpharma
    November 20, 2020
    ​Lonza has made additional investments in its oral drug product development and manufacturing capabilities at its Tampa, FL site. Capability for formulation development has been enhanced with the upgrade of drug product development laboratories for ...
PharmaSources Customer Service